Cinacalcet HCl
Sponsors
Amgen, Montefiore Medical Center, Kyowa Kirin Co., Ltd., ENRICO VERRINA, Kyowa Kirin China Pharmaceutical Co., Ltd.
Conditions
Chronic Kidney DiseaseChronic Kidney Disease, Secondary HyperparathyroidismHypercalcemiaHyperparathyroidism; Secondary, RenalKidney DiseaseParathyroid CarcinomaPrimary HyperparathyroidismSecondary Hyperparathyroidism
Phase 1
Phase 2
Phase 3
Cinacalcet HCl in Chronic Kidney Disease Subjects With Secondary Hyperparathyroidism Not Receiving Dialysis
CompletedNCT00094484
Start: 2004-10-31Target: 400Updated: 2013-05-08
An Intra-individual Titration Study of KRN1493 for the Treatment of Hypercalcemia in Patients With Parathyroid Carcinoma or Intractable Primary Hyperparathyroidism
CompletedNCT01460030
Start: 2011-11-30End: 2013-02-28Updated: 2017-03-03
Efficacy and Safety of Cinacalcet in Pediatric Patients With Secondary Hyperparathyroidism (SHPT) and Chronic Kidney Disease (CKD) on Dialysis
TerminatedNCT02138838
Start: 2014-11-07End: 2016-06-23Updated: 2020-06-29